Federated Hermes’s Verastem VSTM Stock Holding History

Federated Hermes’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,648	Closed	-$7.92K	–	2196
2024 Q3	$7.92K	Buy	+2,648	New	+$7.18K	﹤0.01%	1821
2022 Q1	–	Sell	-5,179	Closed	-$127K	–	2326
2021 Q4	$127K	Buy	5,179 +187	+4%	+$5.9K	﹤0.01%	1687
2021 Q3	$184K	Buy	4,992 +58	+1%	+$2.13K	﹤0.01%	1674
2021 Q2	$241K	Buy	+4,934	New	+$206K	﹤0.01%	1649
2018 Q3	–	Sell	-81	Closed	-$7K	–	2328
2018 Q2	$7K	Buy	+81	New	+$4.96K	﹤0.01%	1968
2017 Q4	–	Sell	-52	Closed	-$3K	–	2230
2017 Q3	$3K	Sell	52 -56	-52%	-$2.64K	﹤0.01%	2029
2017 Q2	$3K	Hold	108	–	–	﹤0.01%	2016
2017 Q1	$3K	Hold	108	–	–	﹤0.01%	2003
2016 Q4	$1K	Hold	108	–	–	﹤0.01%	2068
2016 Q3	$2K	Hold	108	–	–	﹤0.01%	2032
2016 Q2	$2K	Buy	+108	New	+$1.9K	﹤0.01%	2003

Other funds holding VSTM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's VSTM Position: Q4 2024 in Review

Federated Hermes sold out of Verastem (VSTM) in Q4 2024, closing a stake of 2,648 shares — an estimated $7.92K sold.

Federated Hermes first reported a position in VSTM in Q2 2016 and held it in 11 quarters. The position peaked at $241K in Q2 2021. 92 funds tracked by Wall St. Rank hold VSTM as of Q4 2024.

Federated Hermes reported no remaining Verastem position as of Q4 2024 after selling out during the quarter.
Federated Hermes sold 2,648 Verastem shares in Q4 2024, an estimated $7.92K.
Federated Hermes first reported a position in Verastem in Q2 2016 and held it in 11 quarters.
Federated Hermes's Verastem position peaked at $241K in Q2 2021.
92 funds tracked by Wall St. Rank held Verastem as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.